Devyani Deshpande

2.3k total citations
58 papers, 1.7k citations indexed

About

Devyani Deshpande is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Devyani Deshpande has authored 58 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Infectious Diseases, 42 papers in Epidemiology and 20 papers in Pharmacology. Recurrent topics in Devyani Deshpande's work include Tuberculosis Research and Epidemiology (49 papers), Mycobacterium research and diagnosis (35 papers) and Antibiotics Pharmacokinetics and Efficacy (20 papers). Devyani Deshpande is often cited by papers focused on Tuberculosis Research and Epidemiology (49 papers), Mycobacterium research and diagnosis (35 papers) and Antibiotics Pharmacokinetics and Efficacy (20 papers). Devyani Deshpande collaborates with scholars based in United States, South Africa and India. Devyani Deshpande's co-authors include Tawanda Gumbo, Shashikant Srivastava, Jotam G. Pasipanodya, Pooi S Lee, Gesham Magombedze, Soumya Swaminathan, Eric L. Nuermberger, Claudia Meek, Richard D. Leff and Beatriz E. Ferro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Devyani Deshpande

57 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Devyani Deshpande United States	26	1.3k	1.1k	428	276	273	58	1.7k
Deepak V. Almeida United States	27	1.7k 1.3×	1.5k 1.3×	168 0.4×	252 0.9×	227 0.8×	51	2.1k
Shashikant Srivastava United States	32	2.2k 1.7×	1.8k 1.6×	727 1.7×	393 1.4×	364 1.3×	126	2.9k
Khye Seng Goh Guadeloupe	27	1.2k 0.9×	1.3k 1.2×	158 0.4×	174 0.6×	236 0.9×	52	1.7k
Claudia Meek United States	16	781 0.6×	642 0.6×	256 0.6×	147 0.5×	63 0.2×	27	1.3k
Wiel C.M. de Lange Netherlands	20	913 0.7×	838 0.7×	219 0.5×	51 0.2×	282 1.0×	47	1.6k
Si-Yang Li United States	18	979 0.7×	819 0.7×	86 0.2×	140 0.5×	106 0.4×	27	1.2k
Salman H. Siddiqi United States	20	2.3k 1.7×	2.4k 2.1×	114 0.3×	227 0.8×	502 1.8×	43	2.9k
Jansy P. Sarathy United States	20	1.2k 0.9×	810 0.7×	134 0.3×	200 0.7×	35 0.1×	38	1.5k
Rokeya Tasneen United States	20	1.4k 1.1×	998 0.9×	165 0.4×	189 0.7×	30 0.1×	35	1.7k
Pamela J. Lindholm-Levy United States	20	1.1k 0.8×	1.0k 0.9×	88 0.2×	127 0.5×	102 0.4×	23	1.3k

Countries citing papers authored by Devyani Deshpande

Since Specialization

Citations

This map shows the geographic impact of Devyani Deshpande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devyani Deshpande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devyani Deshpande more than expected).

Fields of papers citing papers by Devyani Deshpande

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devyani Deshpande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devyani Deshpande. The network helps show where Devyani Deshpande may publish in the future.

Co-authorship network of co-authors of Devyani Deshpande

This figure shows the co-authorship network connecting the top 25 collaborators of Devyani Deshpande. A scholar is included among the top collaborators of Devyani Deshpande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devyani Deshpande. Devyani Deshpande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deshpande, Devyani, Shashikant Srivastava, & Tawanda Gumbo. (2024). Ertapenem's therapeutic potential for Mycobacterium avium lung disease in the hollow fibre model. International Journal of Antimicrobial Agents. 64(3). 107204–107204. 3 indexed citations

Deshpande, Devyani, Gesham Magombedze, Shashikant Srivastava, & Tawanda Gumbo. (2024). Antibacterial action of penicillin against Mycobacterium avium complex. SHILAP Revista de lepidopterología. 1(8). 362–368. 1 indexed citations

Gumbo, Tawanda, Shashikant Srivastava, Devyani Deshpande, et al.. (2023). Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development. Journal of Antimicrobial Chemotherapy. 78(4). 953–964. 7 indexed citations

Deshpande, Devyani, et al.. (2023). Ceftriaxone Efficacy for Mycobacterium avium Complex Lung Disease in the Hollow Fiber and Translation to Sustained Sputum Culture Conversion in Patients. The Journal of Infectious Diseases. 230(2). e230–e240. 3 indexed citations

Deshpande, Devyani, Shashikant Srivastava, Jotam G. Pasipanodya, & Tawanda Gumbo. (2022). Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy. Frontiers in Pharmacology. 13. 1024608–1024608.

Srivastava, Shashikant, Jann‐Yuan Wang, Gesham Magombedze, et al.. (2021). Novel Short-Course Therapy and Morphism Mapping for Clinical Pulmonary Mycobacterium kansasii. Antimicrobial Agents and Chemotherapy. 65(5). 7 indexed citations

Gumbo, Tawanda, Carleton M. Sherman, Devyani Deshpande, Jan‐Willem C. Alffenaar, & Shashikant Srivastava. (2021). Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration. International Journal of Infectious Diseases. 104. 680–684. 8 indexed citations

Deshpande, Devyani, Jotam G. Pasipanodya, Shashikant Srivastava, et al.. (2018). Gatifloxacin Pharmacokinetics/Pharmacodynamics–based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis. Clinical Infectious Diseases. 67(suppl_3). S274–S283. 20 indexed citations

Deshpande, Devyani, Shashikant Srivastava, Eric L. Nuermberger, et al.. (2018). Multiparameter Responses to Tedizolid Monotherapy and Moxifloxacin Combination Therapy Models of Children With Intracellular Tuberculosis. Clinical Infectious Diseases. 67(suppl_3). S342–S348. 19 indexed citations

10.

Deshpande, Devyani, Shashikant Srivastava, & Tawanda Gumbo. (2017). A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting. Journal of Antimicrobial Chemotherapy. 72(suppl_2). i54–i60. 13 indexed citations

11.

Deshpande, Devyani, Shashikant Srivastava, Moti Chapagain, et al.. (2017). The discovery of ceftazidime/avibactam as an anti-Mycobacterium avium agent. Journal of Antimicrobial Chemotherapy. 72(suppl_2). i36–i42. 32 indexed citations

12.

Deshpande, Devyani, Shashikant Srivastava, Jotam G. Pasipanodya, & Tawanda Gumbo. (2017). Linezolid as treatment for pulmonary Mycobacterium avium disease. Journal of Antimicrobial Chemotherapy. 72(suppl_2). i24–i29. 24 indexed citations

13.

Deshpande, Devyani, Shashikant Srivastava, Jotam G. Pasipanodya, Pooi S Lee, & Tawanda Gumbo. (2017). A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease. Journal of Antimicrobial Chemotherapy. 72(suppl_2). i48–i53. 23 indexed citations

14.

Srivastava, Shashikant, Devyani Deshpande, Carleton M. Sherman, & Tawanda Gumbo. (2017). A ‘shock and awe’ thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium–intracellulare complex disease. Journal of Antimicrobial Chemotherapy. 72(suppl_2). i43–i47. 14 indexed citations

15.

Deshpande, Devyani, Shashikant Srivastava, Jotam G. Pasipanodya, Pooi S Lee, & Tawanda Gumbo. (2017). Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease. Journal of Antimicrobial Chemotherapy. 72(suppl_2). i30–i35. 32 indexed citations

16.

Srivastava, Shashikant, Jotam G. Pasipanodya, Geetha Ramachandran, et al.. (2016). A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies. EBioMedicine. 6. 126–138. 38 indexed citations

17.

Deshpande, Devyani, Shashikant Srivastava, Jotam G. Pasipanodya, et al.. (2016). Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps. Clinical Infectious Diseases. 63(suppl 3). S80–S87. 34 indexed citations

18.

Deshpande, Devyani, Shashikant Srivastava, Eric L. Nuermberger, et al.. (2016). A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way. Clinical Infectious Diseases. 63(suppl 3). S95–S101. 41 indexed citations

19.

Srivastava, Shashikant, Devyani Deshpande, Jotam G. Pasipanodya, et al.. (2016). A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground. Clinical Infectious Diseases. 63(suppl 3). S75–S79. 13 indexed citations

20.

Srivastava, Shashikant, Devyani Deshpande, Jotam G. Pasipanodya, et al.. (2016). Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks. Clinical Infectious Diseases. 63(suppl 3). S102–S109. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact